We are live on ! Find out more
CIC

Chase Investment Counsel Portfolio holdings

AUM $474M
1-Year Est. Return 95.11%
This Fund
S&P 500
This Quarter Est. Return
-9.78%
1 Year Est. Return
+95.11%
3 Year Est. Return
+349.64%
5 Year Est. Return
+621.11%
10 Year Est. Return
+3,935.08%
AUM
$168M
AUM Growth
-$26.3M
Cap. Flow
-$4.46M
Cap. Flow %
-2.66%
Top 10 Hldgs %
35.7%
Holding
116
New
28
Increased
12
Reduced
47
Closed
25

Top Buys

Rank Stock Value
1
USG
Usg
USG
+$4.45M
2
DG icon
Dollar General
DG
+$3.17M
3
MRK icon
Merck
MRK
+$3.02M
4
MOS icon
The Mosaic Company
MOS
+$3M
5
ERIC icon
Ericsson
ERIC
+$2.86M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$5.43M
2
AAPL icon
Apple
AAPL
+$4.16M
3
SSNC icon
SS&C Technologies
SSNC
+$3.65M
4
VOYA icon
Voya Financial
VOYA
+$3.62M
5
FDX icon
FedEx
FDX
+$3.46M

Sector Composition

Rank Sector Weight
1 Healthcare 20.57%
2 Technology 19.28%
3 Financials 12.54%
4 Consumer Discretionary 12.1%
5 Industrials 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WP
26
DELISTED
Worldpay, Inc.
WP
$2.63M 1.57%
34,388
-19,024
-36% -$1.65M
PYPL icon
27
PayPal
PYPL
$50.5B
$2.62M 1.56%
+31,165
New +$2.6M
CSX icon
28
CSX Corp
CSX
$93.1B
$2.21M 1.32%
106,695
-633
-0.6% -$14.6K
TMO icon
29
Thermo Fisher Scientific
TMO
$220B
$2.12M 1.26%
9,459
-145
-2% -$34K
WBD icon
30
Warner Bros
WBD
$67.1B
$2.03M 1.21%
+81,959
New +$2.5M
UAL icon
31
United Airlines
UAL
$42.1B
$1.96M 1.17%
+23,435
New +$2.06M
BIB icon
32
ProShares Ultra NASDAQ Biotechnology
BIB
$86.2M
$1.95M 1.16%
46,396
– –
TMUS icon
33
T-Mobile US
TMUS
$190B
$1.81M 1.08%
+28,438
New +$1.91M
ELV icon
34
Elevance Health
ELV
$85.5B
$1.77M 1.05%
+6,734
New +$1.85M
EPAM icon
35
EPAM Systems
EPAM
$5.03B
$1.52M 0.91%
13,108
+1,005
+8% +$123K
CEF icon
36
Sprott Physical Gold and Silver Trust
CEF
$8.06B
$1.52M 0.91%
121,070
-1,980
-2% -$23.5K
PRAH
37
DELISTED
PRA Health Sciences, Inc.
PRAH
$1.46M 0.87%
15,827
-1,158
-7% -$117K
KL
38
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$1.4M 0.83%
53,608
+687
+1% +$14.6K
EEFT icon
39
Euronet Worldwide
EEFT
$2.7B
$1.38M 0.82%
13,500
+5,930
+78% +$657K
CIEN icon
40
Ciena
CIEN
$58.4B
$1.35M 0.8%
+39,799
New +$1.26M
OLLI icon
41
Ollie's Bargain Outlet
OLLI
$4.94B
$1.34M 0.8%
20,105
-2,052
-9% -$171K
EBS icon
42
Emergent Biosolutions
EBS
$248M
$1.31M 0.78%
22,032
+4,618
+27% +$298K
KEYS icon
43
Keysight
KEYS
$58.3B
$1.27M 0.76%
20,449
+3,568
+21% +$215K
ISRG icon
44
Intuitive Surgical
ISRG
$134B
$1.26M 0.75%
+7,920
New +$1.34M
XYZ
45
Block Inc
XYZ
$47.5B
$1.14M 0.68%
+20,300
New +$1.43M
DECK icon
46
Deckers Outdoor
DECK
$13.3B
$1.03M 0.62%
+48,456
New +$983K
GDXJ icon
47
VanEck Junior Gold Miners ETF
GDXJ
$8.46B
$1.03M 0.62%
34,198
– –
MSCI icon
48
MSCI
MSCI
$40.9B
$1.02M 0.61%
6,955
-3,630
-34% -$553K
SIGI icon
49
Selective Insurance
SIGI
$5.73B
$1.02M 0.61%
+16,804
New +$1.05M
MMSI icon
50
Merit Medical Systems
MMSI
$5.32B
$1M 0.6%
17,978
-2,460
-12% -$146K
1
2
3 4 5

Similar funds

KC
Keenan Capital Burlingame, California $474M AUM 2.41% 1-Year Est. Return
PCM
Pamplona Capital Management New York $473M AUM 3.78% 1-Year Est. Return
RCM
Rivermont Capital Management New York $475M AUM 116.05% 1-Year Est. Return
CCM
CoreView Capital Management Hong Kong $473M AUM 14.25% 1-Year Est. Return
CTWM
Cherry Tree Wealth Management Minnetonka, Minnesota $473M AUM 12.37% 1-Year Est. Return
MCA
MSH Capital Advisors Scottsdale, Arizona $472M AUM 16.23% 1-Year Est. Return
BSI
Bregal Sagemount IV St. Helier $472M AUM
AL4A
Accel Leaders 4 Associates Palo Alto, California $475M AUM 391.52% 1-Year Est. Return

Chase Investment Counsel's Q4 2018 Portfolio in Review

As of Q4 2018, Chase Investment Counsel held 116 positions worth $168M, down 14% from $194M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Chase Investment Counsel's Q4 2018 filing shows 28 new, 12 increased, 47 reduced and 25 closed positions. Its largest new stake was Usg: 103,982 shares worth $4.43M. The largest sale was Celanese, an estimated $5.43M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

  • Chase Investment Counsel's largest Q4 2018 buy was Usg: 103,982 shares worth $4.43M.
  • Chase Investment Counsel added most to Merck in Q4 2018, an estimated $3.02M increase.
  • Chase Investment Counsel's biggest Q4 2018 reduction was Apple, cutting an estimated $4.16M.
  • Chase Investment Counsel fully exited Celanese in Q4 2018, selling an estimated $5.43M.
  • Chase Investment Counsel's ten largest holdings make up 36% of its $168M portfolio in Q4 2018.
  • Chase Investment Counsel opened 28 new positions and closed 25 in Q4 2018.
  • Chase Investment Counsel's portfolio value fell 14% quarter-over-quarter to $168M.

Based on Chase Investment Counsel's 13F filing for Q4 2018, filed 4 Feb 2019.